 |
 |
||
 |
 |
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
|
||
|
||||||
Discerna was established in 2001 on the expertise of its founders in immunology and protein engineering. Recognising the commercial potential of recombinant protein-based products, particularly antibodies, the Company has created a platform of technologies that both improve upon and complement established methods of developing biopharmaceuticals. |
||||||
